| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $4.3M | +45.4% | -9.3% |
| SG&A Expense | $1.9M | -15.5% | -23.5% |
| Operating Income | -$6.3M | -18.5% | +14.1% |
| Interest Expense | $6K | — | -91.1% |
| Net Income | -$6.1M | -19.3% | +14.7% |
| EPS (Basic) | -$0.77 | +21.4% | -67.4% |
| EPS (Diluted) | -$0.77 | +21.4% | -67.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.5M | -17.8% | -15.8% |
| Current Assets | $21.8M | -16.3% | -11.7% |
| Total Assets | $22.5M | -16.1% | -12.4% |
| Current Liabilities | $3.0M | +82.8% | +106.3% |
| Total Liabilities | $3.2M | +70.5% | +82.8% |
| Stockholders' Equity | $19.3M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.5M | -146.8% | — |
| Financing Cash Flow | $10.5M | +0.0% | — |
| -19.5% |